Minor cell-death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and Bmf

Oncogene

Volumn 32, Issue 5, 2013, Pages 621-630

  Baumgartner, F ^a   Woess, C ^a   Pedit, V ^a   Tzankov, A ^b   Labi, V ^a,c   Villunger, A ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF BASEL   (Switzerland)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

apoptosis; Bad; BH3 only proteins; Bmf; cancer; hematopoiesis

Indexed keywords

BH3 PROTEIN; BIM PROTEIN; GLUCOCORTICOID; HISTONE DEACETYLASE; PROTEIN BAD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; FOLLOW UP; HOMEOSTASIS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYMOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; B-LYMPHOCYTES; BCL-ASSOCIATED DEATH PROTEIN; CELL DEATH; CELL TRANSFORMATION, NEOPLASTIC; HEMATOPOIESIS; HOMEOSTASIS; LYMPHOCYTES; MICE; MICE, KNOCKOUT;

MUS;

EID: 84873412465     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.78     Document Type: Article

References (33)

1. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47-59.
2. Chipuk JE, Green DR. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 2008; 18: 157 - 164.
3. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002; 2: 183 - 192. (Pubitemid 41043974)
4. Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR et al. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 2005; 17: 525 - 535. (Pubitemid 40269117)
5. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17: 393 - 403. (Pubitemid 40193310)
6. Maiuri MC, Le TG, Criollo A, Rain JC, Gautier F, Juin P et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 2007; 26: 2527 - 2539. (Pubitemid 46788315)
7. Danial NN. BAD: undertaker by night, candyman by day. Oncogene 2008; 27 (Suppl 1): S53 - S70.
8. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008; 135: 1311 - 1323.
9. Ranger AM, Zha J, Harada H, Datta SR, Danial NN, Gilmore AP et al. Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003; 100: 9324 - 9329. (Pubitemid 37033927)
10. Kelly PN, White MJ, Goschnick MW, Fairfax KA, Tarlinton DM, Kinkel SA et al. Individual and overlapping roles of BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets and in suppression of thymic lymphoma development. Cell Death Differ 2010; 17: 1655 - 1664.
11. Frenzel A, Labi V, Chmelewskij W, Ploner C, Geley S, Fiegl H et al. Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad. Blood 2010; 115: 995 - 1005.
12. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y et al. Regulation of PTEN transcription by p53. Mol Cell 2001; 8: 317 - 325. (Pubitemid 32831549)
13. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2: 489 - 501. (Pubitemid 37328931)
14. Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009; 9: 550 - 562.
15. Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB et al. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 2000; 6: 41 - 51.
16. Lee JW, Soung YH, Kim SY, Nam SW, Kim CJ, Cho YG et al. Inactivating mutations of proapoptotic Bad gene in human colon cancers. Carcinogenesis 2004; 25: 1371 - 1376. (Pubitemid 39162703)
17. Teo K, Gemmell L, Mukherjee R, Traynor P, Edwards J. Bad expression influences time to androgen escape in prostate cancer. BJU Int 2007; 100: 691 - 696. (Pubitemid 47205461)
18. Kuroda J, Puthalakath H, Cragg MS, Kelly PN, Bouillet P, Huang DC et al. Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic. Proc Natl Acad Sci USA 2006; 103: 14907 - 14912. (Pubitemid 44527827)
19. Gilmore AP, Valentijn AJ, Wang P, Ranger AM, Bundred N, O'Hare MJ et al. Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor. J Biol Chem 2002; 277: 27643 - 27650. (Pubitemid 34966707)
20. Danial NN, Gramm CF, Scorrano L, Zhang CY, Krauss S, Ranger AM et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 2003; 424: 952 - 956. (Pubitemid 37051687)
21. Puthalakath H, Villunger A, O'Reilly LA, Beaumont JG, Coultas L, Cheney RE et al. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 2001; 293: 1829 - 1832. (Pubitemid 32845780)
22. Pinon JD, Labi V, Egle A, Villunger A. Bim and Bmf in tissue homeostasis and malignant disease. Oncogene 2008; 27(Suppl 1): S41 - S52.
23. Labi V, Erlacher M, Kiessling S, Manzl C, Frenzel A, O'Reilly L et al. Loss of the BH3- only protein Bmf impairs B cell homeostasis and accelerates gamma irradiationinduced thymic lymphoma development. J Exp Med 2008; 205: 641 - 655. (Pubitemid 351439310)
24. Ploner C, Rainer J, Niederegger H, Eduardoff M, Villunger A, Geley S et al. The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia 2008; 22: 370 - 377. (Pubitemid 351250542)
25. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286: 1735 - 1738. (Pubitemid 129515880)
26. Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, Coultas L et al. BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoidinduced apoptosis of lymphoid cells in vivo. Blood 2005; 106: 4131- 4138. (Pubitemid 41775918)
27. Erlacher M, Labi V, Manzl C, Bock G, Tzankov A, Hacker G et al. Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med 2006; 203: 2939 - 2951. (Pubitemid 46026171)
28. Coultas L, Bouillet P, Stanley EG, Brodnicki TC, Adams JM, Strasser A. Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death. Mol Cell Biol 2004; 24: 1570 - 1581. (Pubitemid 38167079)
29. Hubner A, Cavanagh-Kyros J, Rincon M, Flavell RA, Davis RJ. Functional cooperation of the proapoptotic Bcl2 family proteins Bmf and Bim in vivo. Mol Cell Biol 2010; 30: 98 - 105.
30. Zhao Y, Coloff JL, Ferguson EC, Jacobs SR, Cui K, Rathmell JC. Glucose metabolism attenuates p53 and Puma-dependent cell death upon growth factor deprivation. J Biol Chem 2008; 283: 36344 - 36353.
31. Wang P, Kang D, Cao W, Wang Y, Liu Z. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev 2011; 28: 109 - 122.
32. Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA et al. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 2009; 15: 5073 - 5081.
33. Villunger A, Huang DC, Holler N, Tschopp J, Strasser A. Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD. J Immunol 2000; 165: 1337 - 1343. (Pubitemid 30604563)